Deutsche Bank AG vs Twist Bioscience Corp — how do they compare? Deutsche Bank AG trades at $35.39 (market cap $67.54B), while Twist Bioscience Corp trades at $93.17 (market cap $5.63B). The key difference: Deutsche Bank AG is far larger — about 12× Twist Bioscience Corp's market cap, and Deutsche Bank AG pays a 3.3% dividend while Twist Bioscience Corp pays none. Which is the better fit depends on your goals.
| DB | TWST | |
|---|---|---|
Market Cap | $67.54B | $5.63B |
Sector | Financials | Health |
52-Week High | $40.33 | $102.88 |
52-Week Low | $28.37 | $24.16 |
Dividend Yield | 3.3% | — |
Enterprise Value | — | $5.55B |
Trailing returns across standard periods
In July 2019, Deutsche Bank announced another restructuring plan hoping to revitalize revenue, reduce costs, and return to profitability. The largest moving pieces of the new plan is the full exit of global equity sales & trading, the scaling back of its fixed income business, as well as 18,000 FTE reductions until 2022. The remaining core business segments include private banking, corporate banking, asset management, and investment banking.
Read more on DB →Twist Bioscience Corp is a synthetic biology company. It develops a disruptive DNA synthesis platform to industrialize the engineering of biology. The company's DNA synthesis platform utilizes a proprietary semiconductor-based synthetic DNA manufacturing process that synthesizes DNA on silicon instead of on traditional well plastic plates to enable the production of high-quality synthetic DNA faster and affordable as well as overcomes inefficiencies. Powering cost-effective, rapid high-throughput synthesis, it enables researchers to rapidly realize opportunities ahead. Geographically, it derives a majority of revenue from the United States.
Read more on TWST →